Abstract

The dissociating and/or residual inhibitory effects of bopindolol from β-adrenoceptors (ARs) of atria strips pretreated with this drug and washed out with buffers on isoprenaline-induced chronotropic actions were determined. The effects of this drug were compared with those of its active metabolite 18-502, propranolol, and pindolol. Our results are as follows: (1) Lower concentrations of bopindolol (10<sup>–9</sup> and 10<sup>–8</sup> mol/l) and the active metabolite 18-502 (10<sup>–9</sup> mol/l), propranolol (10<sup>–8</sup> and 10<sup>–6</sup> mol/l) and pindolol (10<sup>–8</sup> mol/l) produced rightward shifts of concentration-response curves of isoprenaline. (2) Higher concentrations of bopindolol (10<sup>–7</sup> mol/l) and 18-502 (10<sup>–8</sup> and 10<sup>–7</sup> mol/l) produced a reduced maximum response by isoprenaline. (3) Bopindolol (10<sup>–9</sup>–10<sup>–7</sup> mol/l), 18-502 (10<sup>–9</sup>–10<sup>–7</sup> mol/l) and propranolol (10<sup>–7</sup> and 10<sup>–6</sup> mol/l) did not recover to control levels at 180 min even after washout with buffers. In conclusion, bopindolol and 18-502 may slowly dissociate and act as noncompetitive β-antagonists rather than readily reversible β-AR antagonists. These effects may differ from those of propranolol and pindolol, although propranolol did not recover to control levels after washout with buffer.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.